AzTrials
AzTrials

Perioperative ComplicationTROPUTILENCT04286685

Development of a New Prognostic Assessment Tool for Postoperative Myocardial Injury

An observational study of Perioperative Complication and Myocardial Injury, run by University Hospital, Brest at 2 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Myocardial injury after noncardiac surgery (MINS) is common, silent, and strongly associated with morbi-mortality. There are some evidences in the littérature showing that troponin elevation pre and/or postoperatively and surgical Apgar score are strongly and independently associated with postoperative… Read more about this study

Who is it for?
Ages 50 to 100 yearsHealthy volunteers can take part
Conditions the study is for
Perioperative Complication, Myocardial Injury
How many people
1,600 participants
Where
2 sitesFrance
Study dates
7 Jan 2020to 7 Apr 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients aged of 50 years and more, with elective orthopedic surgery in Brest community-affiliated hospital

Who may be able to join

  • > 50 years
  • orthopedic surgery (hip, knee, spine)
  • written consent

Who cannot join

  • no troponin measurement prior surgery
  • sepsis
  • acute coronary syndrome
  • pulmonary embolism
  • refusing to participate
  • guardianship

Trial locations and contacts

2 sites in 1 country.

Olivier HUET, MD,PhD contact

+33298347288

olivier.huet@chu-brest.fr

Anaïs CAILLARD, MD contact

+33298347288

anais.caillard@chu-brest.fr

France2 sites, 2 recruiting
  • CHRU Brest

    Brest, 29200

    Olivier HUET, MD, PhD, +33298347288, olivier.huet@chu-brest.fr

    Anaïs CAILLARD, MD, +33298347288, anais.caillard@chu-brest.fr

    Recruiting
  • CHU Rennes

    Rennes, 35033

    Hélène BELOEIL, MD, PhD, helene.beloeil@chu-rennes.fr

    Recruiting

Other trials in France

About this study

Official title: Development of a New Prognostic Assessment Tool for Postoperative Myocardial Injury : the TROPUTILE Score. A Non-interventional Prospective Study

Myocardial injury after noncardiac surgery (MINS) is common, silent, and strongly associated with morbi-mortality.

There are some evidences in the littérature showing that troponin elevation pre and/or postoperatively and surgical Apgar score are strongly and independently associated with postoperative morbi-mortality.

In this cohort study of orthopedic surgery patients (> 50years), the aim is to determine MINS incidence and to assess wich peri-operative factors are associated with the occurrence of MINS. The final objective is to create a score to better identified the patients with a MINS and a poor outcome.

Keywords
Non cardiac surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative MINS incidence

    Troponin elevation > 5ng/l compared to previous measurement OR troponin elevation > 65 ng/l

    Measured: 3 days after surgery

Secondary outcomes (9)
  1. Number of Participants with cardiac arrest

    Cardiac arrest

    Measured: 3 months

  2. Number of Participants with an episode of acute pulmonary oedema

    Acute pulmonary oedema

    Measured: 3 months

  3. Number of Participants with coronary angioplasty

    Coronary angioplasty

    Measured: 3 months

  4. Number of Participants with myocardial infarction

    Myocardial infarction

    Measured: 3 months

  5. Number of Participants with stroke

    Stroke

    Measured: 3 months

  6. Number of Participants with transient stroke

    Transient stroke

    Measured: 3 months

  7. Mortality rate

    Death

    Measured: 3 months

  8. Revised Cardiac Risk Index for Pre-Operative Risk (Lee score)

    Minimum value = 0 Minimum value = 0, maximum value = 6, higher scores mean a worse outcome (higher peri operative mortality risk)

    Measured: Inclusion

  9. Metabolic Equivalent of Task (MET)

    Minimum value = 1, Maximum value= 10, a low score (MET <4) is associated with a capacity to do some light intensity activities and is associated with cardiovascular risk.

    Measured: Inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2020
  2. Study start7 Jan 2020
  3. Primary completion7 Apr 2025 (estimated)
  4. Study completion7 Apr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04286685
Sponsor's protocol ID
29BRC19.0202 (TROPUTILE)
Acronym
TROPUTILE
Status last verified
Dec 2023
First submitted
25 Feb 2020
Last updated
7 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All collected data that underlie results in a publication

Questions about this trial

What is this clinical trial studying?

An observational study of Perioperative Complication and Myocardial Injury, run by University Hospital, Brest at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Olivier HUET, MD,PhD (+33298347288, olivier.huet@chu-brest.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative MINS incidence (time frame: 3 days after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in